Web Stats Provided By Google Analytics

Wednesday, August 14, 2013

U.S. approval of Tivicay (dolutegravir) for the treatment of HIV-1 announced

... that our singular focus on HIV can deliver important new medicines, maintaining our absolute commitment to the HIV/AIDS global response," said Dr Dominique Limet, Chief Executive Officer, ViiV Healthcare. The submission included data from four ...

http://www.medilexicon.com/medicalnews.php?newsid=264772

No comments:

Post a Comment